1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Atossa Therapeutics Inc (ATOS)

  7. Atossa Therapeutics Inc (ATOS) Financials

ATOS

Atossa Therapeutics Inc
0.6766
-0.0027 (-0.4%)
Upgrade to Real-Time

Atossa Therapeutics Inc. (ATOS) Fundamentals
Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
SHARE INFORMATION
Market CapUS$ 90,675,525
Shares Outstanding126,624,110
Float126,565,081
Percent Float99.95%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0.18
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions152
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months227,879
Institutional Holdings Percent27.5%
Institutional Sold Previous 3 Months11,643,284
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months-
Insider Holdings Percent0.4
Insider Sold Previous 3 Months-
Insider Shares Owned549,108
TRADING INFO
52 Week HighUS$ 1.62
52 Week LowUS$ 0.50
52 Week High ChangeUS$ -54.10
21 Day Moving AverageUS$ 0.7041
21 Day Extended Moving AverageUS$ 0.703311
50 Day Moving AverageUS$ 0.7582
50 Day Extended Moving AverageUS$ 0.727087
200 Day Moving AverageUS$ 0.856513
200 Day Extended Moving AverageUS$ 0.924154
10 Day Average Volume325,640
20 Day Average Volume316,049
30 Day Average Volume347,909
50 Day Average Volume481,631
Alpha0.001903
Beta1.2460
Standard Deviation0.367573
R20.033323
7 Day Price ChangeUS$ 0.0661
7 Day Percent Change10.17%
21 Day Price ChangeUS$ -0.0162
21 Day Percent Change-2.21%
30 Day Price ChangeUS$ -0.0039
30 Day Percent Change-0.54%
Month to Date Price ChangeUS$ -0.0239
Month to Date Percent Change-3.23%
Quarter to Date Price ChangeUS$ 0.1876
Quarter to Date Percent Change35.5%
180 Day Price ChangeUS$ -0.1334
180 Day Percent Change-15.7%
200 Day Price ChangeUS$ -0.1967
200 Day Percent Change-21.55%
Year to Date Price ChangeUS$ 0.1876
Year to Date Percent Change35.5%

Atossa Therapeutics Inc. (ATOS) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio43.00
Leverage Ratio1.00
Quick Ratio41.10
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio0.90
Enterprise ValueUS$ -55,530,806
Price to Sales0.00
Price to Free Cash-5.20
PE High Last 5 Years-0.50
Price To Book0.70
Price To Cash Flow0.00
PE Low Last 5 Years-0.40
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-19.61
Return on Equity-19.95
Return on Capital-18.33

Atossa Therapeutics Inc. (ATOS) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEOSteven C. Quay
Emplyoees6
Last AuditUE
CIK0001488039
IndustryBiotechnology
SectorHealthcare
NAICSIn-Vitro Diagnostic Substance Manufacturing(325413)
CONTACT INFO
Address107 Spring Street
Seattle, WA 98104
Websitehttps://www.atossatherapeutics.com
Facsimile+1 206 902-9658
Telephone+1 206 325-6068
Emailkyle.guse@atossainc.com
Your Recent History
NASDAQ
ATOS
Atossa The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 08:29:27